rs10818854
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001352964.2(DENND1A):c.303-7710C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0577 in 152,152 control chromosomes in the GnomAD database, including 296 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.058 ( 296 hom., cov: 32)
Consequence
DENND1A
NM_001352964.2 intron
NM_001352964.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.389
Publications
53 publications found
Genes affected
DENND1A (HGNC:29324): (DENN domain containing 1A) Clathrin (see MIM 118955)-mediated endocytosis is a major mechanism for internalization of proteins and lipids. Members of the connecdenn family, such as DENND1A, function as guanine nucleotide exchange factors (GEFs) for the early endosomal small GTPase RAB35 (MIM 604199) and bind to clathrin and clathrin adaptor protein-2 (AP2; see MIM 601024). Thus, connecdenns link RAB35 activation with the clathrin machinery (Marat and McPherson, 2010 [PubMed 20154091]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0818 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DENND1A | NM_001352964.2 | c.303-7710C>T | intron_variant | Intron 5 of 23 | ENST00000394215.7 | NP_001339893.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DENND1A | ENST00000394215.7 | c.303-7710C>T | intron_variant | Intron 5 of 23 | 5 | NM_001352964.2 | ENSP00000377763.4 |
Frequencies
GnomAD3 genomes AF: 0.0577 AC: 8779AN: 152034Hom.: 296 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8779
AN:
152034
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0577 AC: 8782AN: 152152Hom.: 296 Cov.: 32 AF XY: 0.0601 AC XY: 4470AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
8782
AN:
152152
Hom.:
Cov.:
32
AF XY:
AC XY:
4470
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
3291
AN:
41496
American (AMR)
AF:
AC:
853
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
241
AN:
3466
East Asian (EAS)
AF:
AC:
290
AN:
5176
South Asian (SAS)
AF:
AC:
428
AN:
4824
European-Finnish (FIN)
AF:
AC:
622
AN:
10594
Middle Eastern (MID)
AF:
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2861
AN:
68008
Other (OTH)
AF:
AC:
128
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
412
824
1237
1649
2061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
194
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.